Detection and Quantification of Small Numbers of Circulating Tumour Cells in Peripheral Blood Using Laser Scanning Cytometer (LSC®)
- 7 January 2001
- journal article
- research article
- Published by Walter de Gruyter GmbH in cclm
- Vol. 39 (9) , 811-817
- https://doi.org/10.1515/cclm.2001.134
Abstract
The detection of circulating tumour cells disseminated from solid tumours requires extremely sensitive methods. Molecular genetic methods, which are most sensitive, are not applicable to solid tumours because no tumour-specific genetic markers are available. Detection of disseminated tumour cells by immunocytochemistry is time-consuming, whereas fluorimetry is fast and quantitative. The laser scanning cytometer (LSC®) provides an automated microscopic procedure for screening up to 5×104 cells in suitable time. Using this system together with an enrichment procedure which allows up to ten thousand-fold enrichment, we have quantified minimal numbers of tumour cells. In a model system, breast cancer cell line cells diluted into peripheral blood mimicked seeding of tumour cells into the periphery. After staining with fluorochrome-conjugated anti-epithelial antibody, slides were screened for positive events directly or after enrichment with antibody-coated magnetic beads. One positive cell was unequivocally detectable in 104 cells and 50 out of 60 tumour cells were reliably recovered from a 20 ml blood volume, equal to 1–2 cells per 107, after magnetic bead enrichment. This method allows quantitation of tumour cells in peripheral blood and bone marrow in reasonable time and will, for the first time, enable extensive investigation of the seeding behaviour of tumours.Keywords
This publication has 22 references indexed in Scilit:
- Detection of rare MCF-7 breast carcinoma cells from mixtures of human peripheral leukocytes by magnetic deposition analysisCytometry, 1999
- Molecular detection of minimal residual disease in colorectal and breast cancerHistopathology, 1999
- Consequences of Nucleic Acid Amplification Testing for Blood Transfusion CentresVox Sanguinis, 1998
- Minimal Residual Disease in Solid Tumor Malignancies: A ReviewJournal of Hematotherapy, 1998
- Comparison of Molecular Cytokeratin 19 Reverse Transcriptase Polymerase Chain Reaction (CK19 RT-PCR) and Immunocytochemical Detection of Micrometastatic Breast Cancer Cells in Hematopoietic HarvestsJournal of Hematotherapy, 1997
- Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapyBone Marrow Transplantation, 1997
- Detection of Minimal Disease in Patients with Solid TumorsJournal of Hematotherapy, 1996
- Polymerase chain reaction in the detection of micrometastases and circulating tumor cellsCancer, 1996
- Detection of Minimal Residual Disease in Hematopoietic TissuesAnnals of the New York Academy of Sciences, 1995
- Detection of immunocytochemically stained rare events using image analysisCytometry, 1994